Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Lilly has guided to a Q2-Q3 2026 readout for TRIUMPH-1, the pivotal 80-week general-obesity trial
Phase 3 is the larger, longer-running stage that determines whether the drug gets regulatory approval for human use
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied for obesity and type 2 diabetes
102 and 103novel and non-obvious
What semaglutide actually does Semaglutide is a GLP-1 receptor agonist, which means it mimics a hormone involved in appetite regulation, digestion, and blood sugar control
US$ 24.39
US$ 28.59
US$ 23.46
US$ 28.71
US$ 27.50
US$ 28.91
US$ 27.48
US$ 23.69
US$ 23.96
US$ 1142.99
Sold : Login>>
